Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

First documentation of isoniazid reversion in Mycobacterium tuberculosis.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease - 1 Nov 2009

Richardson E T, Lin S-Y G, Pinsky B A, Desmond E, Banaei N

Abstract excerpt

BACKGROUND: Drug-resistant strains of Mycobacterium tuberculosis are increasing worldwide and pose a major threat to global health. However, it remains unsettled whether drug-resistant mutants are fixed in the bacterial population or if they would revert in the absence of drug pressure. OBJECTIVE...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antitubercular Agents
Share to Catalase
Share to Drug Resistance, Multiple, Bacterial

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Therapy, Combination

Share to Genetic Fitness

Share to Isoniazid

Share to Sputum

Share to Tuberculosis, Multidrug-Resistant

Source

Identifiers

PMID: 19861005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19861005-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

First documentation of isoniazid reversion in Mycobacterium tuberculosis.PMID 19861005Read ↗

Longitudinal whole genome analysis of pre and post drug treatment Mycobacterium tuberculosis isolates reveals progressive steps to drug resistance.Semantic proximity Read ↗

Genetic mechanisms of co-emergence of INH-resistant Mycobacterium tuberculosis strains during the standard course of antituberculosis therapy.Semantic proximity Read ↗

Isoniazid-resistant tuberculosis: a cause for concern?Semantic proximity Read ↗

Prevalence of mutations in genes associated with isoniazid resistance in Mycobacterium tuberculosis isolates from re-treated smear-positive pulmonary tuberculosis patients: A meta-analysis.Semantic proximity Read ↗

Sources of Multidrug Resistance in Patients With Previous Isoniazid-Resistant Tuberculosis Identified Using Whole Genome Sequencing: A Longitudinal Cohort StudySemantic proximity Read ↗

Resistant mutants of Mycobacterium tuberculosis selected in vitro do not reflect the in vivo mechanism of isoniazid resistance.Semantic proximity Read ↗

The mechanism of isoniazid killing: clarity through the scope of genetics.Semantic proximity Read ↗

Two Novel katG Mutations Conferring Isoniazid Resistance in Mycobacterium tuberculosisSemantic proximity Read ↗

Validation of novel <i>Mycobacterium tuberculosis</i> isoniazid resistance mutations not detectable by common molecular testsSemantic proximity Read ↗

Contribution of efflux to the emergence of isoniazid and multidrug resistance in Mycobacterium tuberculosis.Semantic proximity Read ↗

Molecular characterization of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from the USASemantic proximity Read ↗

Detecting novel genetic variants associated with isoniazid-resistant Mycobacterium tuberculosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.